Professor Chris Gale, Deputy Director of Imperial Clinical Trials Unit (ICTU)
We are delighted to welcome Professor Chris Gale as the new Deputy Director of Imperial Clinical Trials Unit (ICTU).
A Professor of Neonatal Medicine, he brings extensive trial experience, with a particular interest in data enabled trials.
Professor Gale is currently leading on several large, pragmatic, international neonatal trials, including the WHEAT trial based at ICTU, as well as involvement in other UK and international neonatal and maternity research. He played a key role in developing the international CONSORT guidance to improve reporting of trials that use routine data (CONSORT-ROUTINE), and involve babies, children, adolescents and young people (CONSORT-CHILDREN).
Professor Gale's career has focused on improving outcomes for preterm babies and sick children, through both clinical and research practice. Alongside work as consultant neonatologist at Chelsea and Westminster Hospital, he leads national perinatal brain injury surveillance for the Department of Health and Social Care in England. He also leads observational and trial research aiming to reduce perinatal brain injuries.
Professor Gale’s other activities include chairing the NIHR Research for Patient Benefit London Regional Funding Panel, coupled with coordination of academic training across the London School of Paediatrics.
Professor Gale says:
“I am excited to join ICTU. I was lucky enough to work here about 10 years ago, as part of a NIHR Fellowship. I've had a big interest in high quality clinical trials ever since: the opportunities offered by ICTU are huge. I am particularly looking forward to helping expand trial delivery and therapeutic areas like paediatrics and child health."
Article text (excluding photos or graphics) © Imperial College London.
Photos and graphics subject to third party copyright used with permission or © Imperial College London.
Reporter
Anneliese Levy
School of Public Health
